Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Econazole nitrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for The name of your medicine is Gyno-Pevaryl 150mg vaginal pessaries. They are called 'Gyno-Pevaryl 150 pessaries' in this leaflet. This pack contains 3 pessaries. Gyno-Pevaryl 150 pessaries are solid, torpedo-shaped pessaries (vaginal suppositories). When inserted into the vagina they release a medicine called econazole nitrate. This belongs to a group of medicines called 'antifungals'. Gyno-Pevaryl 150 pessaries are used for infections of the vagina and the skin around the vagina. The infections are caused by fungi and yeasts such as thrush (Candida).
e Gyno-Pevaryl 150 pessaries Do not use Gyno-Pevaryl 150 pessaries if:
-1-
Do not use this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before using Gyno-Pevaryl 150 pessaries. Warnings and precautions Talk to your doctor or pharmacist before using Gyno-Pevaryl 150 pessaries if:
Gyno-Pevaryl 150 pessaries Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Using the pessaries • • • • •
Always wash your hands thoroughly before using this medicine. This is particularly important if you are pregnant The full course is 3 pessaries Use one pessary each day, for 3 days Use the pessary just before going to bed. This helps it to stay in place Do not swallow the pessary
Inserting the pessary
•
Push the pessary with your forefinger as far as you can into your vagina (figure 2) 1
2
When to stop using Gyno-Pevaryl 150 pessaries Use the full course of 3 pessaries. Do this, even if the soreness, itching and discharge go away before the end of the course. If you swallow Gyno-Pevaryl 150 pessaries If a pessary is eaten or swallowed talk to a doctor or go to the nearest hospital casualty department straight away. If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop using Gyno-Pevaryl 150 pessaries and tell your doctor straight away if you notice the following. You may need urgent medical treatment.
-3-
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.
Gyno-Pevaryl 150 pessaries Keep this medicine out of the sight and reach of children. Store in the original container. Do not store above 30°C. Keep away from heat and sunlight. Do not use Gyno-Pevaryl 150 pessaries:
What Gyno-Pevaryl 150 pessaries contain The active substance is econazole nitrate. Each pessary contains 150 mg econazole nitrate. The other ingredients are Wecobee M and Wecobee FS. What Gyno-Pevaryl 150 pessaries looks like and contents of the pack Gyno-Pevaryl 150 pessaries come in a plastic strip containing 3 pessaries. The pessaries are torpedo-shaped and white to off-white in colour. Marketing Authorisation Holder: Karo Pharma AB, Box 16184, 103 24 Stockholm, Sweden [email protected] Manufacturer: Lusomedicamenta – Sociedade, Técnica Farmacêutica, S.A., Estrada Consiglieri Pedroso, 69-B, Queluz de Baixo, 2730-055 Barcarena, Portugal This leaflet was last revised in June 2023.
-4-
Gyno-Pevaryl 150 mg Vaginal Pessaries comes as pessary containing 150mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Gyno-Pevaryl 150 mg Vaginal Pessaries is econazole nitrate.
Medicines with the same active substance, strength and form include: Gyno-Pevaryl Once 150mg vaginal pessary. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Gyno-Pevaryl 150 mg Vaginal Pessaries, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Vaginitis due to Candida albicans and other yeasts.
For vaginal administration.
Adults:
One pessary should be inserted high into the vagina each evening for three consecutive days. Pregnant women should thoroughly wash their hands before self-administering Gyno-Pevaryl 150 mg vaginal pessaries.
Children:
Gyno-Pevaryl 150 mg vaginal pessaries are not indicated for use in children under the age of 16 years.
Elderly:
No specific dosage recommendations or precautions apply.
Hypersensitivity to any imidazole preparation, other vaginal antifungal products, or to any ingredients of Gyno-Pevaryl 150mg vaginal pessaries.
For intravaginal use only. This preparation is not for oral use.
Hypersensitivity has rarely been recorded; if it should occur administration should be discontinued.
Contact between contraceptive diaphragms or condoms and this product must be avoided since the rubber may be damaged by the preparation.
Patients using spermicidal contraceptives should consult their physician since any local vaginal treatment may inactivate the spermicidal contraceptive (see section 4.5).
Gyno-Pevaryl 150mg vaginal pessaries should not be used in conjunction with other internal or external treatment of the genitalia.
Econazole is a known inhibitor of CYP3A4/2C9. Due to the limited systemic availability after vaginal application (see Section 5.2. Pharmacokinetic Properties), clinically relevant interactions are unlikely to occur but have been reported with oral anticoagulants. In patients taking oral anticoagulants, such as warfarin or acenocoumarol, caution should be exercised and the anticoagulant effect should be monitored more frequently.
Adjustment of the oral anticoagulant dosage may be necessary during and after the treatment with econazole.
Contact between latex products such as contraceptive diaphragms or condoms and this product must be avoided since the constituents of the product may damage the latex. Patients using spermicidal contraceptives should consult their physician since any local vaginal treatment may inactivate the spermicidal contraceptive (see section 4.4).
Pregnancy
In animals, econazole nitrate has shown no teratogenic effects but is foetotoxic at high doses. The significance of this to man is unknown as there is no evidence of an increased risk when taken in human pregnancy. However, animal studies have shown reproductive toxicity (see section 5.3). Because there is vaginal absorption, as with other imidazoles, econazole should be used in pregnancy only if the practitioner considers it to be necessary.
Breast-feeding
Following oral administration of econazole nitrate to lactating rats, econazole and/or metabolites were excreted in milk and were found in nursing pups. It is not known whether econazole nitrate is excreted in human milk. Caution should be exercised when using Gyno-Pevaryl 150mg vaginal pessaries if the patient is breast-feeding
Fertility
Results of econazole animal reproduction studies showed no effects on fertility.
None known.
The safety of Gyno-Pevaryl Vaginal Cream and Vaginal Pessaries was evaluated in 3630 patients who participated in 32 clinical trials.
Based on pooled safety data from these clinical trials, the most commonly reported adverse reactions were (with % incidence) pruritus (1.2%) and skin burning sensation (1.2%).
Including the above mentioned adverse reactions, the following table displays adverse reactions that have been reported with the use of Gyno-Pevaryl Vaginal Cream and Vaginal Pessaries from either clinical trial or postmarketing experiences. The displayed frequency categories use the following convention:
Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); and not known (cannot be estimated from the available clinical trial data). All adverse reactions with a known incidence (common or uncommon) are from clinical trial data and all adverse reactions with an unknown incidence are from post-marketing data.
Adverse Reactions
System Organ Class
Adverse Reactions
Frequency Category
Common
(≥1/100 to <1/10)
Uncommon
(≥1/1,000 to <1/100)
Rare
(≥1/10,000 to <1/1,000)
Not known
Immune System Disorders
Hypersensitivity
Skin and Subcutaneous Tissue Disorders
Pruritus, Skin burning sensation
Rash
Erythema
Angioedema, Urticaria, Contact dermatitis, Skin exfoliation
Reproductive System and Breast Disorders
Vulvovaginal burning sensation
General Disorders and Administration Site Conditions
Application site pain, Application site irritation, Application site swelling
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Adverse events associated with overdose or misuse of Gyno-Pevaryl Vaginal Pessaries are expected to be consistent with adverse drug reactions already listed in Section 4.8. (Undesirable effects).
In the event of accidental ingestion, nausea, vomiting and diarrhoea may occur. If necessary treat symptomatically.
Ask anything about Gyno-Pevaryl 150 mg Vaginal Pessaries. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.